- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Submit a Manuscript
- Subscription Information
- Table of Contents
Volume 2013 (2013), Article ID 840964, 6 pages
Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population
1Department of Family and Community Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, 9849 Kenworthy Street, El Paso. TX 79924, USA
2Department of Biostatistics, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, 9849 Kenworthy Street, El Paso. TX 79924, USA
Received 21 December 2012; Accepted 10 January 2013
Academic Editors: R.-J. Bensadoun, A. Celetti, A. M. Garcia-Lora, and G. Gatti
Copyright © 2013 Eribeth K. Penaranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010.
- P. A. Wingo, C. J. Cardinez, S. H. Landis, L. A. G. Ries, R. N. Anderson, and M. J. Thun, “Long-term trends in cancer mortality in the United States, 1930–1998,” Cancer, vol. 97, no. 12, supplement, pp. 3133–3275, 2003.
- A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010.
- F. X. Bosch, A. Lorincz, N. Muñoz, C. J. L. M. Meijer, and K. V. Shah, “The causal relation between human papillomavirus and cervical cancer,” Journal of Clinical Pathology, vol. 55, no. 4, pp. 244–265, 2002.
- V. Bouvard, R. Baan, K. Straif et al., “A review of human carcinogens—part B: biological agents,” The Lancet Oncology, vol. 10, no. 4, pp. 321–322, 2009.
- M. Schiffman, N. Wentzensen, S. Wacholder, W. Kinney, J. C. Gage, and P. E. Castle, “Human papillomavirus testing in the prevention of cervical cancer,” Journal of the National Cancer Institute, vol. 103, no. 5, pp. 368–383, 2011.
- N. Li, S. Franceschi, R. Howell-Jones, P. J. F. Snijders, and G. M. Clifford, “Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication,” International Journal of Cancer, vol. 128, no. 4, pp. 927–935, 2011.
- I. W. G. o .t. E. o. C. R. t. Humans, “Human papillomaviruses,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 90, pp. 1–636, 2007.
- S. de Sanjose, W. G. V. Quint, L. Alemany et al., “Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study,” The Lancet Oncology, vol. 11, no. 11, pp. 1048–1056, 2010.
- H. O. Smith, M. F. Tiffany, C. R. Qualls, and C. R. Key, “The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24-year population-based study,” Gynecologic Oncology, vol. 78, no. 2, pp. 97–105, 2000.
- K. A. Ault, “Epidemiology and natural history of human papillomavirus infections in the female genital tract,” Infectious Diseases in Obstetrics and Gynecology, vol. 2006, Article ID 40470, 5 pages, 2006.
- J. Cuzick, A. Szarewski, H. Cubie et al., “Management of women who test positive for high-risk types of human papillomavirus: the HART study,” The Lancet, vol. 362, no. 9399, pp. 1871–1876, 2003.
- A. C. Rodriguez, M. Schiffman, R. Herrero et al., “Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection,” Journal of the National Cancer Institute, vol. 102, no. 5, pp. 315–324, 2010.
- M. R. McCredie, K. J. Sharples, C. Paul et al., “Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study,” The Lancet Oncology, vol. 9, no. 5, pp. 425–434, 2008.
- P. Appleby, V. Beral, A. Berrington De González et al., “Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies,” International Journal of Cancer, vol. 118, no. 6, pp. 1481–1495, 2006.
- L. A. Brinton, R. F. Hamman, G. R. Huggins, et al., “Sexual and reproductive risk factors for invasive squamous cell cervical cancer,” Journal of the National Cancer Institute, vol. 79, no. 1, pp. 23–30, 1987.
- J. S. Smith, J. Green, A. Berrington De Gonzalez et al., “Cervical cancer and use of hormonal contraceptives: a systematic review,” The Lancet, vol. 361, no. 9364, pp. 1159–1167, 2003.
- K. G. M. M. Alberti, R. H. Eckel, S. M. Grundy et al., “Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity,” Circulation, vol. 120, no. 16, pp. 1640–1645, 2009.
- E. Giovannucci, D. M. Harlan, M. C. Archer et al., “Diabetes and cancer: a consensus report,” CA Cancer Journal for Clinicians, vol. 60, no. 4, pp. 207–221, 2010.
- E. Giovannucci and D. Michaud, “The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas,” Gastroenterology, vol. 132, no. 6, pp. 2208–2225, 2007.
- S. Cowey and R. W. Hardy, “The metabolic syndrome: a high-risk state for cancer?” American Journal of Pathology, vol. 169, no. 5, pp. 1505–1522, 2006.
- J. A. Laukkanen, D. E. Laaksonen, L. Niskanen, E. Pukkala, A. Hakkarainen, and J. T. Salonen, “Metabolic syndrome and the risk of prostate cancer in finnish men: a population-based study,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 10, pp. 1646–1650, 2004.
- T. Stocks, A. Lukanova, M. Johansson et al., “Components of the metabolic syndrome and colorectal cancer risk; a prospective study,” International Journal of Obesity, vol. 32, no. 2, pp. 304–314, 2008.
- Centers for Disease Control and Prevention, National Center for Health Statistics, National Health and Nutrition Examination Survey 1999-2000, 2001-2002, 2003-2004, 2005-2006, and 2007-2008 documentation files, vol. 2011.
- “Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—the Evidence Report. National Institutes of Health,” Obesity Research, vol. 6, supplement 2, pp. 51S–209S, 1998.
- J. Green, A. Berrington De Gonzalez, S. Sweetland et al., “Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case—Control Study of Cervical Cancer,” British Journal of Cancer, vol. 89, no. 11, pp. 2078–2086, 2003.
- H. Ulmer, T. Bjørge, H. Concin et al., “Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can),” Gynecologic Oncology, vol. 125, no. 2, pp. 330–335, 2012.
- L. A. Colangelo, S. M. Gapstur, P. H. Gann, A. R. Dyer, and K. Liu, “Colorectal cancer mortality and factors related to the insulin resistance syndrome,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 4, pp. 385–391, 2002.
- M. Trevisan, J. Liu, P. Muti, G. Misciagna, A. Menotti, and F. Fucci, “Markers of insulin resistance and colorectal cancer mortality,” Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 9, pp. 937–941, 2001.
- H. Tulinius, N. Sigfússon, H. Sigvaldason, K. Bjarnadóttir, and L. Tryggvadóttir, “Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders,” Cancer Epidemiology Biomarkers and Prevention, vol. 6, no. 11, pp. 863–873, 1997.
- G. Ursin, M. C. Pike, S. Preston-Martin, G. D'Ablaing, and R. K. Peters, “Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States),” Cancer Causes and Control, vol. 7, no. 3, pp. 391–401, 1996.
- S. H. Jee,, H. Ohrr, W. S. Jae, E. Y. Ji, M. Ji, and J. M. Samet, “Fasting serum glucose level and cancer risk in Korean men and women,” Journal of the American Medical Association, vol. 293, no. 2, pp. 194–202, 2005.
- K. Zendehdel, O. Nyren, C. G. ÖStenson, H. O. Adami, A. Ekbom, and W. Ye, “Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden,” Journal of the National Cancer Institute, vol. 95, no. 23, pp. 1797–1800, 2003.
- G. D. Smith, D. Gunnell, and J. Holly, “Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk,” British Medical Journal, vol. 321, no. 7265, pp. 847–848, 2000.
- J. M. P. Holly, D. J. Gunnell, and G. D. Smith, “Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?” Journal of Endocrinology, vol. 162, no. 3, pp. 321–330, 1999.
- H. Zhang, A. M. Pelzer, D. T. Kiang, and D. Yee, “Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin,” Cancer Research, vol. 67, no. 1, pp. 391–397, 2007.
- K. Mardilovich, S. L. Pankratz, and L. M. Shaw, “Expression and function of the insulin receptor substrate proteins in cancer,” Cell Communication and Signaling, vol. 7, article 14, 2009.
- M. R. Shen, Y. M. Hsu, K. F. Hsu, Y. F. Chen, M. J. Tang, and C. Y. Chou, “Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by αvβ3 integrin signaling,” Carcinogenesis, vol. 27, no. 5, pp. 962–971, 2006.
- M. L. Macheda, S. Rogers, and J. D. Best, “Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer,” Journal of Cellular Physiology, vol. 202, no. 3, pp. 654–662, 2005.
- H. Ulmer, W. Borena, K. Rapp et al., “Serum triglyceride concentrations and cancer risk in a large cohort study in Austria,” British Journal of Cancer, vol. 101, no. 7, pp. 1202–1206, 2009.
- W. Borena, T. Stocks, H. Jonsson et al., “Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study,” Cancer Causes and Control, vol. 22, no. 2, pp. 291–299, 2011.
- H. Iso, A. Ikeda, M. Inoue, S. Sato, and S. Tsugane, “Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts,” International Journal of Cancer, vol. 125, no. 11, pp. 2679–2686, 2009.
- G. K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, and D. Bull, “Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study,” British Medical Journal, vol. 335, no. 7630, pp. 1134–1139, 2007.
- A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” The Lancet, vol. 371, no. 9612, pp. 569–578, 2008.
- E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults,” New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003.
- E. A. Lew and L. Garfinkel, “Variations in mortality by weight among 750,000 men and women,” Journal of Chronic Diseases, vol. 32, no. 8, pp. 563–576, 1979.
- A. Wolk, G. Gridley, M. Svensson et al., “A prospective study of obesity and cancer risk (Sweden),” Cancer Causes and Control, vol. 12, no. 1, pp. 13–21, 2001.
- H. Moller, A. Mellemgaard, K. Lindvig, and J. H. Olsen, “Obesity and cancer risk: a Danish record-linkage study,” European Journal of Cancer A, vol. 30, no. 3, pp. 344–350, 1994.
- E. J. B. Ramos, Y. Xu, I. Romanova et al., “Is obesity an inflammatory disease?” Surgery, vol. 134, no. 2, pp. 329–335, 2003.
- R. C. M. Van Kruijsdijk, E. Van Der Wall, and F. L. J. Visseren, “Obesity and cancer: the role of dysfunctional adipose tissue,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 10, pp. 2569–2578, 2009.
- R. Baker, J. G. Dauner, A. C. Rodriguez et al., “Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection,” Cytokine, vol. 53, no. 3, pp. 282–285, 2011.
- T. J. Kemp, A. Hildesheim, A. García-Piñeres et al., “Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 8, pp. 1954–1959, 2010.
- S. J. Bondy, J. C. Victor, and L. M. Diemert, “Origin and use of the 100 cigarette criterion in tobacco surveys,” Tobacco Control, vol. 18, no. 4, pp. 317–323, 2009.
- S. M. Grundy, “Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy,” Nature Reviews Drug Discovery, vol. 5, no. 4, pp. 295–309, 2006.
- D. T. Villareal, C. M. Apovian, R. F. Kushner, and S. Klein, “Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the Obesity Society,” Obesity Research, vol. 13, no. 11, pp. 1849–1863, 2005.
- S. J. McPhee, T. T. Nguyen, S. J. Shema et al., “Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population,” Preventive Medicine, vol. 35, no. 5, pp. 463–473, 2002.